Patent · US Expired

Methods of screening for compounds that decrease phosphorylation of merlin and may be useful in cancer treatment

US7514207B2 · kind B2 · utility

3Cited by
2References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 13, 2002
Grant dateApr 7, 2009
Priority date
Expiry dateApr 12, 2023

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/505
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present inventions features methods for treating or preventing cancer (e.g., cancer of the central nervous system) by administering a compound that inhibits PAK kinase activity and/or merlin phosphorylation to a mammal (e.g., a human). The invention also provides screening methods for identifying additional inhibitors of PAK kinase activity and/or merlin phosphorylation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.